P3363Severity of lymphoma is associated with aortic FDG uptake assessed by FDG PET/CT imaging
Abstract Introduction There is increasing evidence that metabolic disease burden in lymphoma modifies patients' outcome. However, the impact of disease severity on cardiovascular system remains unknown. Purpose To investigate whether lymphoma is associated with arterial inflammation by examinin...
Saved in:
Published in: | European heart journal Vol. 40; no. Supplement_1 |
---|---|
Main Authors: | , , , , , , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Oxford University Press
01-10-2019
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | Abstract
Introduction
There is increasing evidence that metabolic disease burden in lymphoma modifies patients' outcome. However, the impact of disease severity on cardiovascular system remains unknown.
Purpose
To investigate whether lymphoma is associated with arterial inflammation by examining the relationship between disease burden and arterial F-18 Fluorodeoxyglucose (FDG) uptake assessed by positron emission tomography/computed tomography (PET/CT) in Hodgkin and non-Hodgkin sub-types.
Methods
Sixty-two patients (43 male, mean age 58±18 years) with Hodgkin (n=29) or non-Hodgkin lymphoma (n=33) underwent FDG PET/CT imaging before chemotherapy. Disease severity was quantified by total metabolic tumor volume (TMTV) that represents the volume exhibiting standard uptake values (SUV) ≥41% or ≥2.5 of maximum SUV within lymphoma regions, while aortic FDG uptake assessment was based on target-to-background ratio (TBR). Serum high sensitivity-C-reactive protein (hs-CRP), white blood count (WBC), ratio of neutrophils to lymphocytes (N/L), albumin and lactic acid dehydrogenase (LDH) values were recorded in all the patients.
Results
TMTV measurements correlated significantly with hs-CRP, WBC, N/L ratio, albumin and LDH. (Table) Patients with advanced stage disease (III-IV) had higher aortic TBR values compared to those with stage I-II disease (median 2.19 interquartile range (1.96–2.54) vs. 2.04 (1.83–2.15) p=0.046 respectively). Aortic TBR was related with N/L ratio (R=0.370, p=0.009), while no significant correlation was observed with either WBC or hs-CRP values (p=0.930 and p=0.296, respectively). There were significant associations between aortic TBR uptake and TMTV values even after adjustment for age, sex, LDH, albumin, N/L ratio, as well as for the number of cardiovascular risk factors of each patient (β=0.353, p=0.001, adjusted R2=0.318 for TMTV41%, β=0.442, p=0.001, adjusted R2=0.269 for TMTV2.5).
Table 1. Pearson correlation between indices of lymphomas' severity and serum biomarkers
PET derived measurements
Hs-CRP
P-value
Neutrophils to lymphocytes ratio
P-value
MTV41%
0.306
0.016
0.317
0.026
MTV2.5
0.312
0.013
0.389
0.006
Albumin
LDH
MTV41%
−0.281
0.044
0.465
<0.001
MTV2.5
−0.419
0.002
0.616
<0.001
Conclusions
Aortic wall FDG uptake is related with disease severity and subtype of lymphoma indicating a vascular effect of lymphoma, as well as a new potential role of molecular imaging in cardio-oncology by evaluation of disease severity and its consequences to vascular beds with a single examination. |
---|---|
AbstractList | Abstract
Introduction
There is increasing evidence that metabolic disease burden in lymphoma modifies patients' outcome. However, the impact of disease severity on cardiovascular system remains unknown.
Purpose
To investigate whether lymphoma is associated with arterial inflammation by examining the relationship between disease burden and arterial F-18 Fluorodeoxyglucose (FDG) uptake assessed by positron emission tomography/computed tomography (PET/CT) in Hodgkin and non-Hodgkin sub-types.
Methods
Sixty-two patients (43 male, mean age 58±18 years) with Hodgkin (n=29) or non-Hodgkin lymphoma (n=33) underwent FDG PET/CT imaging before chemotherapy. Disease severity was quantified by total metabolic tumor volume (TMTV) that represents the volume exhibiting standard uptake values (SUV) ≥41% or ≥2.5 of maximum SUV within lymphoma regions, while aortic FDG uptake assessment was based on target-to-background ratio (TBR). Serum high sensitivity-C-reactive protein (hs-CRP), white blood count (WBC), ratio of neutrophils to lymphocytes (N/L), albumin and lactic acid dehydrogenase (LDH) values were recorded in all the patients.
Results
TMTV measurements correlated significantly with hs-CRP, WBC, N/L ratio, albumin and LDH. (Table) Patients with advanced stage disease (III-IV) had higher aortic TBR values compared to those with stage I-II disease (median 2.19 interquartile range (1.96–2.54) vs. 2.04 (1.83–2.15) p=0.046 respectively). Aortic TBR was related with N/L ratio (R=0.370, p=0.009), while no significant correlation was observed with either WBC or hs-CRP values (p=0.930 and p=0.296, respectively). There were significant associations between aortic TBR uptake and TMTV values even after adjustment for age, sex, LDH, albumin, N/L ratio, as well as for the number of cardiovascular risk factors of each patient (β=0.353, p=0.001, adjusted R2=0.318 for TMTV41%, β=0.442, p=0.001, adjusted R2=0.269 for TMTV2.5).
Table 1. Pearson correlation between indices of lymphomas' severity and serum biomarkers
PET derived measurements
Hs-CRP
P-value
Neutrophils to lymphocytes ratio
P-value
MTV41%
0.306
0.016
0.317
0.026
MTV2.5
0.312
0.013
0.389
0.006
Albumin
LDH
MTV41%
−0.281
0.044
0.465
<0.001
MTV2.5
−0.419
0.002
0.616
<0.001
Conclusions
Aortic wall FDG uptake is related with disease severity and subtype of lymphoma indicating a vascular effect of lymphoma, as well as a new potential role of molecular imaging in cardio-oncology by evaluation of disease severity and its consequences to vascular beds with a single examination. Abstract Introduction There is increasing evidence that metabolic disease burden in lymphoma modifies patients' outcome. However, the impact of disease severity on cardiovascular system remains unknown. Purpose To investigate whether lymphoma is associated with arterial inflammation by examining the relationship between disease burden and arterial F-18 Fluorodeoxyglucose (FDG) uptake assessed by positron emission tomography/computed tomography (PET/CT) in Hodgkin and non-Hodgkin sub-types. Methods Sixty-two patients (43 male, mean age 58±18 years) with Hodgkin (n=29) or non-Hodgkin lymphoma (n=33) underwent FDG PET/CT imaging before chemotherapy. Disease severity was quantified by total metabolic tumor volume (TMTV) that represents the volume exhibiting standard uptake values (SUV) ≥41% or ≥2.5 of maximum SUV within lymphoma regions, while aortic FDG uptake assessment was based on target-to-background ratio (TBR). Serum high sensitivity-C-reactive protein (hs-CRP), white blood count (WBC), ratio of neutrophils to lymphocytes (N/L), albumin and lactic acid dehydrogenase (LDH) values were recorded in all the patients. Results TMTV measurements correlated significantly with hs-CRP, WBC, N/L ratio, albumin and LDH. (Table) Patients with advanced stage disease (III-IV) had higher aortic TBR values compared to those with stage I-II disease (median 2.19 interquartile range (1.96–2.54) vs. 2.04 (1.83–2.15) p=0.046 respectively). Aortic TBR was related with N/L ratio (R=0.370, p=0.009), while no significant correlation was observed with either WBC or hs-CRP values (p=0.930 and p=0.296, respectively). There were significant associations between aortic TBR uptake and TMTV values even after adjustment for age, sex, LDH, albumin, N/L ratio, as well as for the number of cardiovascular risk factors of each patient (β=0.353, p=0.001, adjusted R2=0.318 for TMTV41%, β=0.442, p=0.001, adjusted R2=0.269 for TMTV2.5). Table 1. Pearson correlation between indices of lymphomas' severity and serum biomarkers PET derived measurements Hs-CRP P-value Neutrophils to lymphocytes ratio P-value MTV41% 0.306 0.016 0.317 0.026 MTV2.5 0.312 0.013 0.389 0.006 Albumin LDH MTV41% −0.281 0.044 0.465 <0.001 MTV2.5 −0.419 0.002 0.616 <0.001 Conclusions Aortic wall FDG uptake is related with disease severity and subtype of lymphoma indicating a vascular effect of lymphoma, as well as a new potential role of molecular imaging in cardio-oncology by evaluation of disease severity and its consequences to vascular beds with a single examination. |
Author | Sioni, A Pouli, A Stergiou, I Terentes-Printzios, D Kafouris, P Pianou, N Koutagiar, I Giannouli, S Karakitsios, I Gaitanis, A Georgakopoulos, A Tousoulis, D Solomou, E Vlachopoulos, C Hontropoulos, S |
Author_xml | – sequence: 1 givenname: E surname: Solomou fullname: Solomou, E organization: Hippokration General Hospital, First Department of Cardiology, Athens, Greece – sequence: 2 givenname: I surname: Koutagiar fullname: Koutagiar, I organization: Hippokration General Hospital, First Department of Cardiology, Athens, Greece – sequence: 3 givenname: C surname: Vlachopoulos fullname: Vlachopoulos, C organization: Hippokration General Hospital, First Department of Cardiology, Athens, Greece – sequence: 4 givenname: A surname: Georgakopoulos fullname: Georgakopoulos, A organization: Academy of Athens Biomedical Research Foundation, Experimental Surgery, Clinical and Translational Research Centre, Athens, Greece – sequence: 5 givenname: A surname: Sioni fullname: Sioni, A organization: Agios Savvas General Hospital, Department of Hematology, Athens, Greece – sequence: 6 givenname: S surname: Giannouli fullname: Giannouli, S organization: National & Kapodistrian University of Athens, Athens, Greece – sequence: 7 givenname: S surname: Hontropoulos fullname: Hontropoulos, S organization: General Hospital of Athens G. Gennimatas, Department of Hematology, Athens, Greece – sequence: 8 givenname: I surname: Stergiou fullname: Stergiou, I organization: Laiko University General Hospital, Department of Pathophysiology, Athens, Greece – sequence: 9 givenname: P surname: Kafouris fullname: Kafouris, P organization: Academy of Athens Biomedical Research Foundation, Experimental Surgery, Clinical and Translational Research Centre, Athens, Greece – sequence: 10 givenname: I surname: Karakitsios fullname: Karakitsios, I organization: Academy of Athens Biomedical Research Foundation, Experimental Surgery, Clinical and Translational Research Centre, Athens, Greece – sequence: 11 givenname: A surname: Gaitanis fullname: Gaitanis, A organization: Academy of Athens Biomedical Research Foundation, Experimental Surgery, Clinical and Translational Research Centre, Athens, Greece – sequence: 12 givenname: D surname: Terentes-Printzios fullname: Terentes-Printzios, D organization: Hippokration General Hospital, First Department of Cardiology, Athens, Greece – sequence: 13 givenname: N surname: Pianou fullname: Pianou, N organization: Academy of Athens Biomedical Research Foundation, Experimental Surgery, Clinical and Translational Research Centre, Athens, Greece – sequence: 14 givenname: A surname: Pouli fullname: Pouli, A organization: Agios Savvas General Hospital, Department of Hematology, Athens, Greece – sequence: 15 givenname: D surname: Tousoulis fullname: Tousoulis, D organization: Hippokration General Hospital, First Department of Cardiology, Athens, Greece |
BookMark | eNqNkNFKwzAUhoNMcJs-gpAX6HbSNFlzKXObwkDBXngjJUtP1sxtKUmn1Kd3c-K1cODA4Xw_P9-A9PZ-j4TcMhgxUHyMh1CjDu1mjPXXJBMjSLm6IH0m0jRRMhM90gemRCJl_npFBjFuACCXTPbJ2zPnkr_gBwbXdtRbuu12Te13mrpIdYzeON1iRT9dW1PtQ-sMnd8v6KFp9TuePvA4FV11P-fnWTGeFtTt9Nrt19fk0uptxJvfPSTFfFZMH5Ll0-JxerdMTD5RyUpqDlqg5oIhU1muESdVCgyBc1hprqUQKFKWKWkrY3MDlTEmMwYrYa3lQyLOsSb4GAPasgnHBqErGZQnReWfovKsqDwpOnJw5vyh-SfyDcHdcOo |
ContentType | Journal Article |
Copyright | Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2019. For permissions, please email: journals.permissions@oup.com. 2019 |
Copyright_xml | – notice: Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2019. For permissions, please email: journals.permissions@oup.com. 2019 |
DBID | AAYXX CITATION |
DOI | 10.1093/eurheartj/ehz745.0239 |
DatabaseName | CrossRef |
DatabaseTitle | CrossRef |
DatabaseTitleList | CrossRef |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
DocumentTitleAlternate | ESC Congress 2019 together with World Congress of Cardiology 31 August – 4 September 2019, Paris - France |
EISSN | 1522-9645 |
ExternalDocumentID | 10_1093_eurheartj_ehz745_0239 10.1093/eurheartj/ehz745.0239 |
GroupedDBID | --- -E4 .2P .I3 .XZ .ZR 08P 0R~ 18M 1TH 29G 2WC 4.4 482 48X 53G 5GY 5RE 5VS 5WA 5WD 70D AABZA AACZT AAJKP AAMVS AAOGV AAPNW AAPQZ AAPXW AARHZ AASNB AAUAY AAUQX AAVAP ABEUO ABIXL ABKDP ABNHQ ABNKS ABOCM ABPTD ABQLI ABQNK ABWST ABXVV ABZBJ ACGFO ACGFS ACPRK ACUFI ACUTJ ACUTO ACYHN ADBBV ADEYI ADEZT ADGZP ADHKW ADHZD ADIPN ADJQC ADOCK ADQBN ADRIX ADRTK ADVEK ADYVW ADZXQ AEGPL AEGXH AEJOX AEKSI AEMDU AENEX AENZO AEPUE AETBJ AEWNT AFFZL AFIYH AFOFC AFXAL AFXEN AGINJ AGKEF AGQXC AGSYK AGUTN AHMBA AHXPO AIAGR AIJHB AJEEA ALMA_UNASSIGNED_HOLDINGS ALUQC APIBT APWMN ATGXG AXUDD BAWUL BAYMD BCGUY BCRHZ BEYMZ BHONS BTRTY BVRKM C45 CDBKE CS3 CZ4 DAKXR DIK DILTD D~K E3Z EBS EE~ EJD EMOBN ENERS F5P F9B FECEO FLUFQ FOEOM FOTVD FQBLK GAUVT GJXCC GX1 H13 H5~ HAR HW0 HZ~ IOX J21 KAQDR KBUDW KOP KQ8 KSI KSN L7B M-Z M41 M49 MHKGH ML0 N9A NGC NOMLY NOYVH NU- O9- OAUYM OAWHX OB3 OCZFY ODMLO OGROG OJQWA OJZSN OK1 OPAEJ OVD OWPYF P2P PAFKI PEELM PQQKQ Q1. Q5Y R44 RD5 ROL ROX ROZ RUSNO RW1 RXO SEL TCURE TEORI TJX W8F WOQ X7H YAYTL YKOAZ YXANX ZKX ~91 AAYXX CITATION |
ID | FETCH-LOGICAL-c879-b6a30a5ea351e1948aee7d201e0330ba3a655e521496fdcf8c0dccc4cced5fff3 |
ISSN | 0195-668X |
IngestDate | Thu Sep 12 18:57:14 EDT 2024 Wed Sep 11 04:51:48 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | Supplement_1 |
Keywords | Positron Emission Tomography (PET) |
Language | English |
License | This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model) |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c879-b6a30a5ea351e1948aee7d201e0330ba3a655e521496fdcf8c0dccc4cced5fff3 |
ParticipantIDs | crossref_primary_10_1093_eurheartj_ehz745_0239 oup_primary_10_1093_eurheartj_ehz745_0239 |
PublicationCentury | 2000 |
PublicationDate | 20191001 2019-10-01 |
PublicationDateYYYYMMDD | 2019-10-01 |
PublicationDate_xml | – month: 10 year: 2019 text: 20191001 day: 01 |
PublicationDecade | 2010 |
PublicationTitle | European heart journal |
PublicationYear | 2019 |
Publisher | Oxford University Press |
Publisher_xml | – name: Oxford University Press |
SSID | ssj0008616 |
Score | 2.3532271 |
Snippet | Abstract
Introduction
There is increasing evidence that metabolic disease burden in lymphoma modifies patients' outcome. However, the impact of disease... |
SourceID | crossref oup |
SourceType | Aggregation Database Publisher |
Title | P3363Severity of lymphoma is associated with aortic FDG uptake assessed by FDG PET/CT imaging |
Volume | 40 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1La9wwEBabFEovpU-avtChl7I4a69s2T6G7KYpoSUQU3opRpIlmmZ3vST2Ifn1mZFsrRdCmxx6MWYsD_LMZ400zIOQT2AGVCRCGTDF4YCSMhNIqXmgq4zLVCqTCcwdPj5Lv__MZvN4Phr1LaM2tP-qaaCBrjFz9gHa9kyBAPegc7iC1uF6L72fMsbZmYZ5d8EWi2tQWL0U2LpcdMroY85FjQzGR7Mv43bdiAuNI7CauN2WIvl0XmAJ3WJ8vrT9jO705GNX7GY8nB76bGBZXdbtVrbDSd02wMYFdXt_7Y8FtmxZ1-3Cxfx5x6112IuLwaODoZciyn28W_O37MehYzNPAs5tm2GwS91iDAflnLtyk_1q7Yo7dai0nU-tG7WM7rQHrlaWbi-tIP7g_e-bNE72Mad3YwJ9YOI_39khj6awpGHw6Ozribf5GbdNdv1X9LliOZt4RpMBm61dEGZWDjY1xTPytDuN0AMHo-dkpFcvyONvXbzFS_JrC020NrRHEz2_ohs0UUQTdWiiABvq0ER7NFF5bcmApslhQTssvSLF0bw4PA66hhyBytI8kFywUCRasCTSUR5nQuu0Am3rkLFQCiZ4kmjYD8Y5NxX85iqslFKxUrpKjDHsNdld1Sv9hlDJZGT0VBvGKjhzw7tchZLx3Ahl1HS6R_Z7-ZRrV3aldOESrPQCLZ1ASxToHvkMUrzf2LcPGPuOPNnA-T3ZbS5b_YHsXFXtR4uAW_Xfjgs |
link.rule.ids | 315,782,786,27935,27936 |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=P3363Severity+of+lymphoma+is+associated+with+aortic+FDG+uptake+assessed+by+FDG+PET%2FCT+imaging&rft.jtitle=European+heart+journal&rft.au=Solomou%2C+E&rft.au=Koutagiar%2C+I&rft.au=Vlachopoulos%2C+C&rft.au=Georgakopoulos%2C+A&rft.date=2019-10-01&rft.pub=Oxford+University+Press&rft.issn=0195-668X&rft.eissn=1522-9645&rft.volume=40&rft.issue=Supplement_1&rft_id=info:doi/10.1093%2Feurheartj%2Fehz745.0239&rft.externalDocID=10.1093%2Feurheartj%2Fehz745.0239 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0195-668X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0195-668X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0195-668X&client=summon |